Objectives: To investigate response of the community pharmacists to acute back pain consultations by the patients, using doctor of pharmacy degree (Pharm D) final year students as simulated patients.
Method:The study was a cross-sectional study, conducted over a three months period from April 2016 to July 2016 in community pharmacy setting. The study was done at the western area in Saudi Arabia, at three cities: (Jeddah-Mecca-Taif). Convenient sample of 300 pharmacies were chosen. The students appeared in the pharmacy as patients. A check list was filled immediately after the visit. Results: Results of the study showed that most of pharmacies studied were chain pharmacies (67.3%). The response of the pharmacists towards patients' counseling ranges from (6-55%). The majority of the pharmacists did not ask about spreading of the pain (93%), other disease (91%), medications taken (90%), intensity of pain (83.67%), and duration (83%). There was a low response of pharmacists towards self-care, except rarely, who gave advice for back exercise (6.667%). About 98% and above, did not give information about expected drug problems. Referral was given mainly for numbness symptoms (10.67%). Types of medications recommended were diclofenac sodium (44.67%), muscle relaxants (28.67%) and topical NSAIDS (25.33%). About 70%, of the pharmacists did not give advice spontaneously. Counseling time was less than one minute in 67.67% of the cases. Conclusions: The response of community pharmacists, to acute back pain consultations was inadequate, which necessitates educational and training programs in minor disease treatment, and availability of national guidelines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.